Sunvozertinib (DZD-9008) is a covalent/irreversible EGFR tyrosine kinase inhibitor with anticancer activity. Sunvozertinib is effective against EGFRexon20ins and other mutations.
纯度:≥98%
CAS:2370013-12-8